Government Affairs
The Government Affairs division is the Chamber’s lobbying team headquartered in Washington with regional offices across the country. We champion the Chamber’s pro-business priorities and advocate for America’s free enterprise system on Capitol Hill.
Chamber Strength
The Chamber is an effective advocacy organization thanks to its broad membership base, extensive federation network, active grassroots engagement, robust policy experience, strong lobbying expertise, proactive free enterprise agenda, and long-standing pro-business reputation.
Our Influence
The Government Affairs DC and Regional Teams play a vital role in the Chamber’s advocacy efforts and effectiveness through legislative lobbying, subject matter expertise, strategic relationship engagement, coalition participation, and policy monitoring, analysis, and reporting.
Hill Leadership
The Hill Team brings expertise and strategic acumen to shape strategy, build alliances, and drive effective advocacy on both sides of the aisle through direct Capitol Hill engagement.
Beyond the Beltway
The Regional Team cultivates relationships among local, regional, and state chambers, association partners, and businesses large and small to show support for pro-growth legislation in the communities that Members of Congress represent.
Relationship Building
Central to the work of the Government Affairs Team is building stronger relationships with members of Congress that foster trust, support decision-making, enhance credibility and expertise, and promote collaboration to enable effective long-term legislative and political success.
Featured Work
The Growth and Opportunity Imperative for America
The U.S. Chamber believes America needs a national priority for growth, driven by people through innovation and productivity and fostered through sound public policy. That's why we are outlining policies that will help us reach the goal of 3% annual real economic growth.
Learn More
Leadership
Latest Content
- This Hill letter was sent to the Members of the Senate Committee on Commerce, Science, and Transportation, opposing S. 127, the "Pharmacy Benefit Manager Transparency Act."This Hill Letter was sent to Members of the Senate Committee on Commerce, Science, and Transportation, Members of the House Committee on Energy and Commerce, Members of the Senate Committee on the Judiciary, and Members of the House Committee on the Judiciary, raising multiple concerns about the Federal Trade Commission.This Hill Letter was sent to Members of the Senate Committee on Commerce, Science, and Transportation opposing the nomination of Gigi Sohn to be a Commissioner of the FCC.This Hill letter was sent to the Members of the House Committee on Financial Services, on several bills to be considered at the hearing entitled "Empowering Entrepreneurs: Removing Barriers to Capital Access for Small Businesses."This Hill letter was sent to the Members of the House Committee on Financial Services, on several bills to be considered at the hearing entitled, "Sophistication or Discrimination? How the Accredited Investor Definition Unfairly Limits Investment Access for the Non-wealthy and the Need for Reform."This Hill letter was sent to Representative Bryan Steil, on his legislation, the "Putting Investors First Act."This Hill letter was sent to the Members of the U.S. House of Representatives, supporting H.Res.11, "Establishing the Select Committee on the Strategic Competition Between the United States and the Chinese Communist Party."This Key Vote Alert! letter was sent to the Members of the United States Senate supporting S. 1486, the “Pregnant Workers Fairness Act (PWFA),” and the addition of PWFA to the Consolidated Appropriations Act of FY2023.This Hill letter was sent to Members of the U.S. House of Representatives supporting S. 2991, the Countering Human Trafficking Act of 2021.